Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For March 16, 2019

Share:

Top Upgrades

  • Analysts at Barclays upgraded Dollar General Corp. (NYSE: DG) from Equal-Weight to Overweight. Dollar General shares rose 1.1 percent to $115.14 in pre-market trading.
  • B. Riley FBR upgraded Health Insurance Innovations Inc (NASDAQ: HIIQ) from Neutral to Buy. Health Insurance shares rose 5.4 percent to $36.00 in pre-market trading.
  • Wells Fargo upgraded Johnson Controls International PLC (NYSE: JCI) from Market Perform to Outperform. Johnson Controls shares rose 1.6 percent to $36.40 in pre-market trading.
  • Analysts at Bank of America upgraded Elanco Animal Health Inc (NYSE: ELAN) from Neutral to Buy. Elanco Animal Health rose 1 percent to $30.95 in pre-market trading.
  • William Blair upgraded DENTSPLY SIRONA Inc (NASDAQ: XRAY) from Market Perform to Outperform. Dentsply Sirona shares fell 0.2 percent to close at $49.09 on Friday.
  • Goldman Sachs upgraded Okta Inc (NASDAQ: OKTA) from Neutral to Buy. Okta shares rose 4 percent to $82.35 in pre-market trading.
  • Imperial Capital upgraded Drive Shack Inc (NYSE: DS) from In-Line to Outperform. Drive Shack shares closed at $4.54 on Friday.
  • Analysts at KeyBanc upgraded Delphi Technologies PLC (NYSE: DLPH) from Underweight to Sector Weight. Delphi Technologies shares rose 4.16 percent to close at $19.02 on Friday.
  • Goldman Sachs upgraded CarGurus Inc (NASDAQ: CARG) from Neutral to Buy. CarGurus shares fell 1.46 percent to close at $38.52 on Friday.
  • Morgan Stanley upgraded Exelixis, Inc. (NASDAQ: EXEL) from Underweight to Equal-Weight. Exelixis shares gained 1.1 percent to $24.80 in pre-market trading.

 

Top Downgrades

  • Needham downgraded Facebook, Inc. (NASDAQ: FB) from Buy to Hold. Facebook shares fell 0.8 percent to $164.62 in pre-market trading.
  • Credit Suisse downgraded Quest Diagnostics Inc (NYSE: DGX) from Outperform to Neutral. Quest Diagnostics shares rose 0.58 percent to close at $88.45 on Friday.
  • Nomura downgraded Aramark (NYSE: ARMK) from Buy to Neutral. Aramark shares fell 1.2 percent to $29.51 in pre-market trading.
  • Mizuho downgraded Synaptics, Incorporated (NASDAQ: SYNA) from Buy to Neutral. Synaptics fell 17.8 percent to $35.53 in pre-market trading.
  • Stephens & Co. downgraded BioScrip Inc (NASDAQ: BIOS) from Overweight to Equal-Weight. BioScrip shares fell 9.7 percent to $2.51 in pre-market trading.
  • William Blair downgraded Restoration Robotics Inc (NASDAQ: HAIR) from Outperform to Market Perform. Restoration Robotics shares fell 4.4 percent to $0.86 in pre-market trading.
  • Wells Fargo downgraded Ingersoll-Rand PLC (NYSE: IR) from Outperform to Market Perform. Ingersoll-Rand shares rose 0.14 percent to close at $106.10 on Friday.
  • Goldman Sachs downgraded SolarWinds Corp (NYSE: SWI) from Buy to Neutral. SolarWinds shares fell 2.2 percent to $19.65 in pre-market trading.
  • Buckingham downgraded Aptiv PLC (NYSE: APTV) from Buy to Neutral. Aptiv shares rose 1.02 percent to close at $81.96 on Friday.
  • Gabelli & Co. downgraded Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) from Buy to Hold. Tetraphase Pharmaceutical shares fell 0.7 percent to $1.40 in pre-market trading.

 

Top Initiations

  • BTIG Research initiated coverage on Arcus Biosciences Inc (NYSE: RCUS) with a Buy rating. The price target for Arcus Biosciences is set to $20. Arcus Biosciences Fox shares closed at $11.67 on Friday.
  • Goldman Sachs initiated coverage on Cars.com Inc (NYSE: CARS) with a Neutral rating. The price target for Cars.com is set to $23. Cars.com shares closed at $22.72 on Friday.
  • Analysts at Keefe Bruyette & Woods initiated coverage on Western Asset Mortgage Capital Corp (NYSE: WMC) with a Market Perform rating. The price target for Western Asset Mortgage is set to $10.50. Western Asset Mortgage shares closed at $10.51 on Friday.
  • Citigroup assumed coverage on Carter's, Inc. (NYSE: CRI) with a Buy rating. The price target for Carter's is set to $120. Carter's shares closed at $94.85 on Friday.
  • Analysts at BTIG Research initiated coverage on Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) with a Neutral rating. Momenta Pharmaceuticals shares closed at $14.15 on Friday.
 

Related Articles (ARMK + APTV)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
PHXSeaport GlobalInitiates Coverage On
AFCGLake StreetInitiates Coverage On29.0
OSSNoble Capital MarketsUpgrades7.0
NCNOGabelli & Co.Upgrades
HAECJS SecuritiesUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com